It's time for the Lightning Round. Cramer makes the call on viewer favorites.» Read More
July 17- U.S. orthopedics company Stryker Corp on Thursday reported slightly higher second-quarter profit that was in line with Wall Street expectations and said it was always in the market for deals. In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion.
July 17- U.S. orthopedics company Stryker Corp on Thursday reported slightly higher second-quarter profit that was in line with Wall Street expectations on increased sales of reconstructive and surgical products. The company posted net profit of $215 million, or 56 cents per share, compared with a profit of $213 million, or 56 cents per share, a year ago.
*AbbVie raises bid to 53.20/ share from 51.15. *Bid comprises 24.44 stg cash and 0.8960 new AbbVie shares. LONDON, July 14- London- listed drugmaker Shire Plc succumbed to an increased 31 billion pounds takeover offer from Abbvie Inc on Monday, signaling the conclusion to a long-running courtship largely motivated by tax.
NEW YORK, June 19- It's the secret fear of every American parent: failure to launch. The idea used to give Andy Byron the cold sweats. Their 22- year-old son scored a paid summer internship with medical device manufacturer Stryker Corp, with an eye toward a career in medical sales.
June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.
One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.
Jim Cramer thinks there’s something Johnson & Johnson could do, right now, to create significant shareholder value.
More and more foreign buyers are finding the U.K.'s takeover laws difficult to navigate.
Some of Thursday's midday movers:
Some of Wednesday's midday movers:
April 15- ConMed Corp, a surgical device maker that has been fighting off activist investors, is exploring a sale and has contacted large medical device companies to gauge their buyout interest, people familiar with the matter said on Tuesday.
WASHINGTON, March 31- Bariatric weight loss surgery on obese patients with type 2 diabetes helped many to get their blood sugar to healthy levels and to no longer require any diabetes medicines, including insulin, three years after the procedure, according to data presented at a major medical meeting on Monday.
Some of Tuesday's midday movers:
Worried about Washington's next fiscal folly? These stocks should weather the next storm, according to two top money managers.
Stryker CEO Kevin Lobo says his company is in "great shape," and discusses the gradual increase in people electing to have surgery. He also addresses the hit from recall costs.
Check out which companies are making headlines after the bell Thursday:
With Washington's debt battle over, markets will quickly shift focus to earnings and how much the government shutdown actually impacted the economy.
A detailed look at how a tax on medical devices divided so many over the White House's Affordable Care Act.
OptionMonster's Jon Najarian points out what looks to be unusual activity in Stryker and Mako options ahead of their merger announcement.
Stocks ended lower Wednesday, with the Dow and S&P closing in the red for the fifth-straight day, as jitters over budget talks in Washington continued to weigh on markets.